Research peptides like BPC-157 and TB-500 are not approved for human use by regulatory agencies like the FDA
The compounded version of the treatment uses semaglutide, the same active ingredient as Wegovy, and will cost $99 per month for patients with a five-month subscription after the initial payment, versus the $199 Novo will charge
Pricing is brand-stated as of June 2026 and subject to change without notice
No hormonal disruption: Unlike anabolic steroids or some other performance-enhancing compounds, BPC 157 peptide doesnt appear to interfere with natural hormone production or require post-cycle therapy
So, if GLP-1 drugs start strong, why do they sometimes seem ineffective over time
Marshall Davis, owner of Davis Drugs said he expects Kentucky's obesity numbers to drop as GLP-1 drugs rise in popularity